Market Cap ₹124 Cr.
Stock P/E -65.5
P/B 11.2
Current Price ₹53.5
Book Value ₹ 4.8
Face Value 10
52W High ₹85.1
Dividend Yield 0%
52W Low ₹ 46
Piccadily Sugar & Allied Industries Limited, established on March 15, 1993, is a prominent player in the food production sector, particularly known for its sugar manufacturing. The company is registered at the Registrar of Companies in Chandigarh and operates as a non-governmental public entity. With an authorized share capital of INR 400,000,000 and a paid-up capital of INR 232,545,270, the company has a solid financial base to support its operations.The company’s last reported Annual General Meeting (AGM) was held on September 28, 2022, and its balance sheet was last filed on March 31, 2022. The directors of Piccadily Sugar And Allied Industries Limited include Harvinder Singh Chopra, Jai Parkash Kaushik, Madhu Sharma, and Naveen Pawar, who bring a wealth of experience to the company’s strategic direction.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 3 | 6 | 3 | 2 | 1 | 1 | 1 | 0 | 3 | 1 |
Other Income | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Total Income | 4 | 6 | 4 | 2 | 2 | 1 | 1 | 0 | 3 | 2 |
Total Expenditure | 4 | 6 | 5 | 2 | 2 | 2 | 1 | 1 | 3 | 3 |
Operating Profit | -0 | -0 | -0 | -0 | -1 | -1 | 0 | -0 | -1 | -2 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Exceptional Income / Expenses | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 2 |
Profit Before Tax | -1 | -1 | -0 | -1 | -1 | -2 | 2 | -1 | -1 | -0 |
Provision for Tax | 0 | -0 | -0 | -0 | -0 | -0 | 1 | -0 | -0 | -1 |
Profit After Tax | -1 | -1 | -0 | -1 | -1 | -1 | 1 | -1 | -1 | 1 |
Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | -0 |
Profit After Adjustments | -1 | -1 | -0 | -1 | -1 | -1 | 1 | -1 | -1 | 1 |
Adjusted Earnings Per Share | -0.5 | -0.3 | -0.1 | -0.3 | -0.3 | -0.6 | 0.4 | -0.3 | -0.5 | 0.3 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 14 | 12 | 11 | 8 | 7 | 33 | 39 | 24 | 30 | 17 | 5 | 5 |
Other Income | 1 | 1 | 1 | 3 | 5 | 2 | 4 | 5 | 2 | 3 | 1 | 1 |
Total Income | 15 | 14 | 12 | 11 | 13 | 35 | 43 | 29 | 32 | 20 | 6 | 6 |
Total Expenditure | 13 | 11 | 9 | 8 | 10 | 30 | 39 | 25 | 28 | 21 | 8 | 8 |
Operating Profit | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | -1 | -2 | -3 |
Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 4 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 4 |
Profit Before Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | -2 | 0 |
Provision for Tax | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | -1 | -0 | 0 |
Profit After Tax | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 1 | 0 | -2 | -2 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 1 | 0 | -2 | -2 | 0 |
Adjusted Earnings Per Share | -0 | -0.1 | 0 | 0 | -0.1 | 0.1 | 0 | 0.4 | 0 | -0.9 | -0.8 | -0.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -71% | -41% | -31% | -10% |
Operating Profit CAGR | 0% | NAN% | NAN% | NAN% |
PAT CAGR | 0% | NAN% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -8% | 47% | 68% | 30% |
ROE Average | -14% | -9% | -4% | -2% |
ROCE Average | -9% | -7% | -2% | -0% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 | 16 | 14 | 12 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 3 | 4 | 4 | 0 | 4 | 5 | 4 | 4 | 2 | 2 | 15 |
Other Non-Current Liabilities | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -1 | -1 | -2 | -2 |
Total Current Liabilities | 25 | 22 | 24 | 27 | 30 | 38 | 32 | 30 | 29 | 37 | 42 |
Total Liabilities | 43 | 40 | 42 | 41 | 49 | 58 | 51 | 49 | 47 | 51 | 67 |
Fixed Assets | 33 | 32 | 31 | 28 | 37 | 42 | 39 | 35 | 33 | 30 | 27 |
Other Non-Current Assets | 4 | 4 | 4 | 8 | 5 | 2 | 2 | 1 | 2 | 5 | 25 |
Total Current Assets | 6 | 4 | 7 | 5 | 7 | 14 | 11 | 13 | 12 | 16 | 14 |
Total Assets | 43 | 40 | 42 | 41 | 49 | 58 | 51 | 49 | 47 | 51 | 67 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
Cash Flow from Operating Activities | 3 | 1 | 1 | 8 | 1 | 7 | -2 | 0 | 4 | 4 | 4 |
Cash Flow from Investing Activities | -3 | -1 | -1 | -4 | -4 | -7 | 3 | 0 | -1 | -3 | -18 |
Cash Flow from Financing Activities | 0 | -0 | 0 | -4 | 4 | 0 | -2 | -0 | -2 | -1 | 13 |
Net Cash Inflow / Outflow | 0 | -0 | 0 | -0 | 1 | -0 | -1 | 1 | -0 | 0 | -1 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 1 | 1 | 0 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -0.03 | -0.11 | 0.01 | 0.04 | -0.05 | 0.14 | 0.01 | 0.39 | 0.01 | -0.89 | -0.82 |
CEPS(Rs) | 0.89 | 0.96 | 1.08 | 1.13 | 1.09 | 1.57 | 1.57 | 1.9 | 1.39 | 0.35 | 0.42 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 6.55 | 6.44 | 6.45 | 6.49 | 6.43 | 6.58 | 6.58 | 6.98 | 6.99 | 6.06 | 5.24 |
Core EBITDA Margin(%) | 10.39 | 9.14 | 12.66 | 3.08 | -29.86 | 6.9 | 0.47 | -3.7 | 4.2 | -19.36 | -64.74 |
EBIT Margin(%) | 2.21 | 0.87 | 2.96 | 4.63 | 2.48 | 2.78 | 1.92 | 3.41 | 1.26 | -13.51 | -41.83 |
Pre Tax Margin(%) | 0.14 | -1.59 | 0.07 | 1.29 | 0.68 | 1.26 | 0.55 | 1.64 | 0.15 | -15.05 | -42.37 |
PAT Margin (%) | -0.43 | -2.13 | 0.21 | 1.19 | -1.64 | 0.84 | 0.04 | 3.25 | 0.04 | -10.89 | -39.28 |
Cash Profit Margin (%) | 14.47 | 18.25 | 23.73 | 33.32 | 33.95 | 9.31 | 8.37 | 15.79 | 9.25 | 4.29 | 20.41 |
ROA(%) | -0.15 | -0.63 | 0.05 | 0.23 | -0.27 | 0.62 | 0.03 | 1.82 | 0.03 | -4.23 | -3.23 |
ROE(%) | -0.41 | -1.72 | 0.15 | 0.62 | -0.82 | 2.18 | 0.12 | 5.78 | 0.08 | -13.67 | -14.45 |
ROCE(%) | 1.55 | 0.47 | 1.34 | 1.88 | 1.07 | 5.47 | 4.18 | 4.73 | 2.18 | -14.14 | -9.15 |
Receivable days | 0 | 0.38 | 0.53 | 0.92 | 5.9 | 27.28 | 30.12 | 32.4 | 29 | 53.24 | 244.57 |
Inventory Days | 75.86 | 75.19 | 129.89 | 195.27 | 146.37 | 30.12 | 31.46 | 60.82 | 56.95 | 108.66 | 355.14 |
Payable days | 1774.5 | 1428.29 | 2920.99 | 2063.13 | 2426.38 | 581.94 | 463.14 | 706.7 | 623.29 | 1004.57 | 3682.59 |
PER(x) | 0 | 0 | 413.7 | 200.44 | 0 | 43.28 | 444.44 | 12.72 | 2996.23 | 0 | 0 |
Price/Book(x) | 0.62 | 0.59 | 0.62 | 1.24 | 0.97 | 0.94 | 0.55 | 0.72 | 2.27 | 2.78 | 9.63 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.11 | 1.37 | 1.66 | 2.38 | 2.3 | 0.56 | 0.32 | 0.64 | 1.33 | 2.34 | 27.35 |
EV/Core EBITDA(x) | 6.49 | 6.45 | 6.25 | 6.48 | 6.04 | 4.17 | 2.75 | 3.44 | 10.79 | -43.98 | -75.73 |
Net Sales Growth(%) | -30.09 | -14.71 | -13.43 | -25.39 | -5.32 | 342.49 | 17.81 | -38.92 | 24.69 | -41.11 | -72.27 |
EBIT Growth(%) | 124.31 | -66.49 | 194.25 | 16.74 | -49.32 | 487.82 | -22.82 | 13.58 | -53.87 | -685.01 | 21.34 |
PAT Growth(%) | 91.02 | -319.29 | 108.64 | 316.39 | -231.01 | 369.38 | -94.29 | 4734.26 | -98.64 | 0 | 8.39 |
EPS Growth(%) | 91.02 | -319.1 | 108.64 | 316.39 | -231.01 | 369.38 | -94.3 | 4741.98 | -98.65 | 0 | 8.4 |
Debt/Equity(x) | 0.46 | 0.55 | 0.57 | 0.02 | 0.28 | 0.35 | 0.28 | 0.28 | 0.21 | 0.19 | 1.25 |
Current Ratio(x) | 0.22 | 0.19 | 0.3 | 0.17 | 0.24 | 0.37 | 0.33 | 0.44 | 0.42 | 0.42 | 0.33 |
Quick Ratio(x) | 0.1 | 0.1 | 0.07 | 0.07 | 0.13 | 0.28 | 0.2 | 0.27 | 0.22 | 0.27 | 0.24 |
Interest Cover(x) | 1.07 | 0.35 | 1.03 | 1.38 | 1.38 | 1.83 | 1.4 | 1.93 | 1.14 | -8.79 | -77.23 |
Total Debt/Mcap(x) | 0.75 | 0.93 | 0.92 | 0.01 | 0.29 | 0.37 | 0.51 | 0.39 | 0.09 | 0.07 | 0.13 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 25.02 | 25.02 | 25.02 | 25.02 | 25.02 | 25.02 | 25.02 | 25.02 | 25.02 | 25.02 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.58 | 0.58 | 0.58 | 0.58 | 0.58 | 0.58 | 0.58 | 0.58 | 0.58 | 0.58 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About